These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 19588351

  • 1. HMG CoA reductase inhibitors (statins) for dialysis patients.
    Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF.
    Cochrane Database Syst Rev; 2009 Jul 08; (3):CD004289. PubMed ID: 19588351
    [Abstract] [Full Text] [Related]

  • 2. HMG CoA reductase inhibitors (statins) for dialysis patients.
    Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF.
    Cochrane Database Syst Rev; 2009 Apr 15; (2):CD004289. PubMed ID: 19370598
    [Abstract] [Full Text] [Related]

  • 3. HMG CoA reductase inhibitors (statins) for dialysis patients.
    Navaneethan SD, Shrivastava R.
    Cochrane Database Syst Rev; 2004 Oct 18; (4):CD004289. PubMed ID: 15495097
    [Abstract] [Full Text] [Related]

  • 4. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
    Navaneethan SD, Perkovic V, Johnson DW, Nigwekar SU, Craig JC, Strippoli GF.
    Cochrane Database Syst Rev; 2009 Apr 15; (2):CD005019. PubMed ID: 19370615
    [Abstract] [Full Text] [Related]

  • 5. HMG CoA reductase inhibitors (statins) for dialysis patients.
    Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Nigwekar SU, Hegbrant J, Strippoli GF.
    Cochrane Database Syst Rev; 2013 Sep 11; 2013(9):CD004289. PubMed ID: 24022428
    [Abstract] [Full Text] [Related]

  • 6. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
    Palmer SC, Navaneethan SD, Craig JC, Perkovic V, Johnson DW, Nigwekar SU, Hegbrant J, Strippoli GF.
    Cochrane Database Syst Rev; 2014 Jan 28; 2014(1):CD005019. PubMed ID: 24470059
    [Abstract] [Full Text] [Related]

  • 7. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Navaneethan SD, Pansini F, Perkovic V, Manno C, Pellegrini F, Johnson DW, Craig JC, Strippoli GF.
    Cochrane Database Syst Rev; 2009 Apr 15; (2):CD007784. PubMed ID: 19370693
    [Abstract] [Full Text] [Related]

  • 8. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Hegbrant J, Strippoli GF.
    Cochrane Database Syst Rev; 2014 May 31; (5):CD007784. PubMed ID: 24880031
    [Abstract] [Full Text] [Related]

  • 9. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Tunnicliffe DJ, Palmer SC, Cashmore BA, Saglimbene VM, Krishnasamy R, Lambert K, Johnson DW, Craig JC, Strippoli GF.
    Cochrane Database Syst Rev; 2023 Nov 29; 11(11):CD007784. PubMed ID: 38018702
    [Abstract] [Full Text] [Related]

  • 10. Lipid-lowering agents for nephrotic syndrome.
    Kong X, Yuan H, Fan J, Li Z, Wu T, Jiang L.
    Cochrane Database Syst Rev; 2013 Dec 10; (12):CD005425. PubMed ID: 24327265
    [Abstract] [Full Text] [Related]

  • 11. Statins for the primary prevention of cardiovascular disease.
    Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, Ward K, Ebrahim S.
    Cochrane Database Syst Rev; 2013 Jan 31; 2013(1):CD004816. PubMed ID: 23440795
    [Abstract] [Full Text] [Related]

  • 12. Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Chou R, Dana T, Blazina I, Daeges M, Jeanne TL.
    JAMA; 2016 Nov 15; 316(19):2008-2024. PubMed ID: 27838722
    [Abstract] [Full Text] [Related]

  • 13. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.
    Nistor I, Palmer SC, Craig JC, Saglimbene V, Vecchio M, Covic A, Strippoli GF.
    Cochrane Database Syst Rev; 2015 May 20; 2015(5):CD006258. PubMed ID: 25993563
    [Abstract] [Full Text] [Related]

  • 14. Statins for the primary prevention of cardiovascular disease.
    Taylor F, Ward K, Moore TH, Burke M, Davey Smith G, Casas JP, Ebrahim S.
    Cochrane Database Syst Rev; 2011 Jan 19; (1):CD004816. PubMed ID: 21249663
    [Abstract] [Full Text] [Related]

  • 15. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials.
    Strippoli GF, Navaneethan SD, Johnson DW, Perkovic V, Pellegrini F, Nicolucci A, Craig JC.
    BMJ; 2008 Mar 22; 336(7645):645-51. PubMed ID: 18299289
    [Abstract] [Full Text] [Related]

  • 16. Meta-analysis of statin therapy in maintenance dialysis patients.
    Sun L, Zou L, Chen M, Liu B.
    Ren Fail; 2015 Aug 22; 37(7):1149-56. PubMed ID: 26139229
    [Abstract] [Full Text] [Related]

  • 17. Vitamin D compounds for people with chronic kidney disease not requiring dialysis.
    Palmer SC, McGregor DO, Craig JC, Elder G, Macaskill P, Strippoli GF.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD008175. PubMed ID: 19821446
    [Abstract] [Full Text] [Related]

  • 18.
    Lozano P, Henrikson NB, Dunn J, Morrison CC, Nguyen M, Blasi PR, Anderson ML, Whitlock E.
    ; 2016 08 07. PubMed ID: 27559556
    [Abstract] [Full Text] [Related]

  • 19. Effect of statins on cardiovascular events in patients with mild to moderate chronic kidney disease: a systematic review and meta-analysis of randomized clinical trials.
    Zhang X, Xiang C, Zhou YH, Jiang A, Qin YY, He J.
    BMC Cardiovasc Disord; 2014 Feb 17; 14():19. PubMed ID: 24529196
    [Abstract] [Full Text] [Related]

  • 20. Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease.
    Rabindranath KS, Adams J, Ali TZ, MacLeod AM, Vale L, Cody J, Wallace SA, Daly C.
    Cochrane Database Syst Rev; 2007 Apr 18; 2007(2):CD006515. PubMed ID: 17443624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.